Suppr超能文献

长期鼻内注射神经生长因子治疗有利于脑组织中神经元的形成。

Long-Term Intranasal Nerve Growth Factor Treatment Favors Neuron Formation in Brain Tissue.

作者信息

Colitti Nina, Desmoulin Franck, Le Friec Alice, Labriji Wafae, Robert Lorenne, Michaux Amandine, Conchou Fabrice, Cirillo Carla, Loubinoux Isabelle

机构信息

Toulouse NeuroImaging Center (ToNIC), Inserm, University of Toulouse (UPS), Toulouse, France.

Unit of Medical Imaging, National Veterinary School of Toulouse, University of Toulouse, Toulouse, France.

出版信息

Front Cell Neurosci. 2022 Jul 19;16:871532. doi: 10.3389/fncel.2022.871532. eCollection 2022.

Abstract

OBJECTIVE

To date, no safe and effective pharmacological treatment has been clinically validated for improving post-stroke neurogenesis. Growth factors are good candidates but low safety has limited their application in the clinic. An additional restraint is the delivery route. Intranasal delivery presents many advantages.

MATERIALS AND METHODS

A brain lesion was induced in twenty-four rats. Nerve growth factor (NGF) 5 μg/kg/day or vehicle was given intranasally from day 10 post-lesion for two periods of five weeks, separated by a two-week wash out period with no treatment. Lesion volume and atrophy were identified by magnetic resonance imaging (MRI). Anxiety and sensorimotor recovery were measured by behavior tests. Neurogenesis, angiogenesis and inflammation were evaluated by histology at 12 weeks.

RESULTS

Remarkable neurogenesis occurred and was visible at the second and third months after the insult. Tissue reconstruction was clearly detected by T2 weighted MRI at 8 and 12 weeks post-lesion and confirmed by histology. In the new tissue (8.1% of the lesion in the NGF group 2.4%, in the control group at 12 weeks), NGF significantly increased the percentage of mature neurons (19% 7%). Angiogenesis and inflammation were not different in the two groups. Sensorimotor recovery was neither improved nor hampered by NGF during the first period of treatment, but NGF treatment limited motor recovery in the second period.

INTERPRETATION

The first five-week period of treatment was very well tolerated. This study is the first presenting the effects of a long treatment with NGF and has shown an important tissue regeneration rate at 8 and 12 weeks post-injury. NGF may have increased neuronal differentiation and survival and favored neurogenesis and neuron survival through subventricular zone (SVZ) neurogenesis or reprogramming of reactive astrocytes. For the first time, we evidenced a MRI biomarker of neurogenesis and tissue reconstruction with T2 and diffusion weighted imaging.

摘要

目的

迄今为止,尚无经临床验证的安全有效的药物治疗方法可用于改善中风后的神经发生。生长因子是很好的选择,但安全性低限制了它们在临床上的应用。另一个限制因素是给药途径。鼻内给药具有许多优点。

材料与方法

对24只大鼠造成脑损伤。从损伤后第10天开始,每天经鼻给予5μg/kg神经生长因子(NGF)或赋形剂,共两个为期五周的疗程,中间有两周的洗脱期,不进行治疗。通过磁共振成像(MRI)确定损伤体积和萎缩情况。通过行为测试测量焦虑和感觉运动恢复情况。在12周时通过组织学评估神经发生、血管生成和炎症。

结果

损伤后第二个月和第三个月出现了显著的神经发生,肉眼可见。在损伤后8周和12周通过T2加权MRI清楚地检测到组织重建,并经组织学证实。在新组织中(12周时,NGF组损伤的8.1%,对照组为2.4%),NGF显著增加了成熟神经元的百分比(19%对7%)。两组的血管生成和炎症没有差异。在治疗的第一个阶段,NGF既没有改善也没有阻碍感觉运动恢复,但在第二个阶段,NGF治疗限制了运动恢复。

解读

治疗的第一个为期五周的阶段耐受性良好。本研究首次展示了长期使用NGF的效果,并显示了损伤后8周和12周时重要的组织再生率。NGF可能增加了神经元分化和存活,并通过脑室下区(SVZ)神经发生或反应性星形胶质细胞重编程促进了神经发生和神经元存活。我们首次通过T2和扩散加权成像证明了神经发生和组织重建的MRI生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c1b/9345199/dad7b2e7be21/fncel-16-871532-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验